Booster COVID-19 mRNA vaccination ameliorates impaired B-cell but not T-cell responses in older adults
2024

Booster COVID-19 mRNA Vaccination Improves B-cell Responses in Older Adults

Sample size: 208 publication 10 minutes Evidence: moderate

Author Information

Author(s): Kometani Kohei, Yorimitsu Takaaki, Jo Norihide, Yamaguchi Erina, Kikuchi Osamu, Fukahori Masaru, Sawada Takeshi, Tsujimoto Yoshitaka, Sunami Ayana, Li Mengqian, Ito Takeshi, Pretemer Yann, Gao Yuxian, Hidaka Yu, Yamamoto Masaki, Kaku Natsuko, Nakagama Yu, Kido Yasutoshi, Grifoni Alba, Sette Alessandro, Nagao Miki, Morita Satoshi, Nakajima Takako E., Muto Manabu, Hamazaki Yoko

Primary Institution: Kyoto University, Kyoto, Japan

Hypothesis

How does booster COVID-19 mRNA vaccination affect T-cell and B-cell responses in older adults compared to younger adults?

Conclusion

Booster vaccination enhances B-cell responses in older adults but does not significantly improve T-cell responses.

Supporting Evidence

  • Older adults showed lower T-cell responses compared to younger adults after vaccination.
  • Booster vaccination significantly increased antibody levels in older adults.
  • Memory B-cell responses in older adults improved to levels comparable with younger adults after the booster.
  • Impaired T-cell activation was observed in older adults even after booster vaccination.
  • Age-related differences in immune responses highlight the need for tailored vaccination strategies.

Takeaway

Getting a booster shot helps older people make better antibodies, but it doesn't help their T-cells as much.

Methodology

The study compared immune responses in older adults and younger adults after receiving three doses of the COVID-19 mRNA vaccine, measuring T-cell and B-cell responses over time.

Potential Biases

Potential biases due to the exclusion of individuals with certain medical conditions and the reliance on self-reported COVID-19 history.

Limitations

The study had a limited number of participants and did not analyze antigen-presenting cells or responses in secondary lymphoid organs.

Participant Demographics

Participants included 103 adults under 65 years and 105 older adults aged 65 years and above.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3389/fimmu.2024.1455334

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication